 |
 |

Neurodevelopment After In Utero Exposure to Phenytoin and Carbamazepine-Reply
Gideon Koren, MD
University of Toronto Toronto, Ontario
JAMA. 1994;272(11):851.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
In Reply.
—Careful reading of our study would have revealed to Dr Jeret that separate analysis of only the epileptic cases did not result in an outcome different from those treated with carbamazepine for nonepileptic indications (top of page 769). Careful reading would have revealed to him also that there was no correlation between the daily dose per kilogram of either phenytoin or carbamazepine and global IQ (page 769). Last, careful reading would have disclosed that this study did not compare the two AEDs with each other, but rather with tightly matched controls. That "full dose" phenytoin is associated with serious neurotoxicity to fetuses is certainly concerning and should be communicated to mothers to be.
Drs Loring, Meador, and Thompson believe that we should have conducted a different analysis than we have done. The essence of their complaint is that we should have compared the phenytoin and carbamazepine cohorts with
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|